Supplements and Featured Publications

Efficacy and Safety of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results of the EXPLORER-HCM Study

The Role of SGLT-2 Inhibitors in Heart Failure: A Roundtable Discussion

Multiple Sclerosis Compendium Newsletter

Type 2 Diabetes: Current Data and Innovative Practices

Understanding the Mechanisms of Multiple Sclerosis Treatments

Slowing Disease Progression in Amyotrophic Lateral Sclerosis: A Review of Guidelines and Current and Emerging Therapies
Volume: 26
Issue: 9

Addressing Unmet Needs in Alzheimer Disease: Implications of Delayed Diagnosis and Examining New and Emerging Therapies
Volume: 26
Issue: 8

The Challenges in Long-Chain Fatty Acid Oxidation Disorders: Unmet Needs of Treatment and Management
Volume: 26
Issue: 7

Optimizing the Use of Molecular Testing in Lung Cancer: An AJMC Stakeholder Interchange Report

Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products

A Path to Improve Colorectal Cancer Screening Outcomes: Faculty Roundtable Evaluation of Cost-Effectiveness and Utility
Volume: 26
Issue: 6

Immunoglobulin Potency and Purity Considerations for Patients With Primary Immunodeficiency
Volume: 1
Issue: 1

Addressing an Unmet Need for Acute Treatment of Migraine

Perspectives on the Value of Icosapent Ethyl

Improving Treatment Strategies for Wet Age-Related Macular Degeneration
Volume: 26
Issue: 5

A Managed Care Review on Insomnia: Treatment Guidelines, Emerging Therapies, and the Need for Safe, Effective Options
Volume: 26
Issue: 4

A Managed Care Review of Schizophrenia: Evaluating Unmet Medical Needs, New Treatments, and Health Economics
Volume: 26
Issue: 3

Managed Care Considerations for Navigating Biosimilar and HER2-Directed Therapies for the Treatment of HER2-Positive Breast Cancer
Volume: 26
Issue: 2

Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies

Rare Disease: Access, Reimbursement, and Disease Management A Stakeholder Interchange Report

The Role of Non-Invasive Vagus Nerve Stimulation in the Migraine Treatment Spectrum
Volume: 26
Issue: 1

Novel Advances in Hereditary Amyloid Transthyretin Amyloidosis: A Stakeholder Interchange Report

Examining the Economic Impact and Implications of Epilepsy

Evaluation of Medical Technologies With Uncertain Benefits

Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea: Disease State and Treatment Overview

New Directions in Immunization Awareness and Engagement

Incremental Healthcare Costs for Persons With Treatment-resistant Depression in Managed Care Organizations

Using Patient Experience Data and Discrete Choice Experiment to Assess Values of Drugs

Exclusive Coverage of the 2019 San Antonio Breast Cancer Symposium

Exclusive Coverage of the 2019 American Society of Hematology Annual Meeting
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5




